8 articles with Betagenon AB
Betagenon AB, a Sweden-based biotech company focused on development of AMPK activator compounds, and MCG Technology Group Ltd, a Hong Kong-based biotech investment group, announced that MCG Technology Group will invest in and collaborate with Betagenon.
Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, announced that James Hall BM, BCh, D.Phil has joined this month as CEO.
Dr. Jan M. Lundberg, Former Head of R&D at AstraZeneca and Eli Lilly has Joined Betagenon's Board of Directors
Dr. Jan M Lundberg brings extensive industrial competence to Betagenon
Betagenon/Baltic Bio Announces Positive Results From a 28-day Phase IIa Trial of the First-in-class AMPK Activator O304 in Type 2 Diabetics
Review of the initial data showed that a number of patients who were included based on HbA1c at screening, had FPG below 7 mM or above 13.3 mM at day 1, and that the data analysis of FPG required a post hoc analysis plan.
Betagenon AB: Start Of Phase IIa Proof-Of-Concept Clinical Trial Of AMPK Activator O304 In Type 2 Diabetics